Foldable glued-IOL procedure successful

Article

The foldable glued-IOL technique provides satisfactory and safe visual outcomes, claims a paper in the latest issue of the Journal of Cataract and refractive Surgery.

The foldable glued-IOL technique provides satisfactory and safe visual outcomes, claims a paper in the latest issue of the Journal of Cataract and refractive Surgery.

Dr Amar Agarwal et al., Dr Agarwal's Eye Hospital and Eye Research Centre, Chennai, India, studied 208 eyes of 185 patients who received a primary glued foldable IOL for intraoperative capsular loss or subluxated lens or secondary glued foldable IOL for aphakia.

The exclusion criteria included preoperative glaucoma, aniridia, macular scar, traumatic subluxation, combined surgeries, incomplete operative medical records and a postoperative follow-up of less than six months. Among the outcome measures were intraoperative and postoperative complication rates, reoperation rate and visual outcomes were analysed.

Intraoperative complications presented were hyphaema, haptic breakage and deformed haptics in 0.4%, 0.4% and 0.9% of patients, respectively. There were early complications in 13.9% of eyes, including corneal oedema, epithelial defect and grade two anterior chamber reaction.

The late complications occurred in 18.7% of eyes and included optic capture, IOL decentration, haptic extrusion, subconjunctival haptic, macular oedema and pigment dispersion.

The group discovered that reoperation was required in 7.7% of eyes and haptic position was altered in eyes with IOL decentration. Corrected distance visual acuity was 20/40 or better in 38.9% of eyes and 20/60 or better in 48.5% of eyes. IOL decentration was caused by haptic-related issues.

For more details on the study please click here.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.